New York, October 09, 2015 -- Moody's Investors Service downgraded St. Jude Medical, Inc.'s senior unsecured ratings to Baa2 from Baa1 following the announcement that the company has closed on its acquisition of Thoratec Corporation. All provisional (P)Baa2 ratings assigned in September 2015 will convert to Baa2. The rating outlook is negative. This concludes Moody's rating review that was initiated on July 22, 2015.
Vollständigen Artikel bei Moodys lesen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.